Online psychoeducation to improve well-being after breast cancer
Official title: The Effect of a Web-Based Supportive Psychoeducation Program on Psychological Well-Being, Quality of Life and Fear of Recurrence Applied to Patients Who Completed Active Breast Cancer Treatment
Run by Uskudar University · NCT07284030 · Data updated 2026-11-12
This trial tests whether a 6-week online psychoeducation program can help women who finished breast cancer treatment at least a year ago feel better psychologically and improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | Women only |
| Enrollment | 72 (estimated) |
| Sponsor | Uskudar University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Istanbul) |
| Status | Recruiting |
| Started | May 1, 2025 |
| Main results expected | December 15, 2025 |
| Study ends | February 1, 2026 |
| Registry record updated | December 16, 2025 |
| Trial ID | NCT07284030 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18-65 who completed active breast cancer treatment at least 12 months ago, are in remission, can read and write Turkish, have internet access and a device for Zoom sessions, and can commit to the 6-week schedule are ideal candidates.
✕Probably not a fit
Patients with active recurrence or metastatic disease, current untreated psychiatric disorders, cognitive impairment, inability to use the internet, or who cannot commit to the online schedule are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial will enroll 72 female breast cancer survivors in remission for at least 12 months and randomly assign them to either a 6-week web-based psychoeducation program plus standard care or to standard care alone. The intervention is delivered weekly via live 30-45 minute Zoom sessions on coping strategies, psychosocial adjustment, meaning, and hope through the onkodestek.org platform. Outcomes including psychological well-being, fear of cancer recurrence, quality of life, and hopelessness are measured at baseline, immediately post-intervention, and at a 2-month follow-up using validated self-report scales. After study completion, participants in the control arm are granted access to the psychoeducation platform.
Why it matters
Potential benefit: If successful, the program could reduce distress and fear of recurrence and improve quality of life for breast cancer survivors using a convenient online format.
How similar studies have gone: Previous web-based psychoeducation and psychosocial programs for cancer survivors have shown modest improvements in psychological outcomes, though results across studies are mixed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female breast cancer survivors * Completed active breast cancer treatment (surgery, chemotherapy, radiotherapy) at least 12 months ago * Currently in remission (no evidence of active disease) * Age between 18-65 years * Able to read and write Turkish * Access to computer or smartphone with internet connection * Able to participate in online video sessions via Zoom * Willing to provide informed consent Exclusion Criteria: * Current cancer recurrence or metastatic disease * Active psychiatric disorder requiring treatment * Cognitive impairment that prevents participation in online sessions * Currently receiving active cancer treatment (excluding hormonal therapy) * Participation in another psychosocial intervention study * No internet access or inability to use web-based platforms * Male breast cancer patients * Unable to commit to 6-week program schedule
Where it's running
-
Breast Cancer Outpatient Clinic
Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Yasemin Nazlı, Clinical Nurse Specialist
- Email: yasemin.nazli@st.uskudar.edu.tr
- Phone: +905325025158
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Breast cancer screening using a new time-domain bioimpedance device
This study tests whether a new TD-BIS scanner can help distinguish healthy breast tissue from cancerous or benign lesions in women during clinical visits.
-
UCF MammoChat mammogram image repository for AI development
This project collects donated mammogram images and questionnaire data from adults who had breast imaging to help build and test AI that could read mammograms more accurately.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.